Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wearable sensor could help kids with breathing issues get better diagnoses

NCT ID NCT06292299

Knowledge-focused Sponsor: NHS Greater Clyde and Glasgow Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a small, wireless wearable device that tracks breathing in children. It aims to see if the device works well for kids who have trouble with standard sleep or breathing tests, including premature infants, children with sleep apnea, and those with epilepsy at risk of sudden death. The goal is to gather data to improve future diagnosis and monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 225 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The target number of participants in this study is 225. 75 patients who fit group 1 characteristics, 75 patients who fit group 2 characteristics and 75 patients who fit group 3 characteristics.

Ages

1 minute to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Group 1 - CR-poly group * Patient undergoing overnight CR-poly * Age birth to \&amp;gt;=16 years * Are willing and able to give informed assent/consent or have available next of Kin to provide informed consent on the participant\&amp;#39;s behalf * Able (in the Investigators opinion) to comply with all study requirements * Can speak and read English Group 2 - Apnoea group * Inpatient in neonatal unit * Age birth (from 30 weeks gestational age) to term corrected * Parents willing and able to give informed consent * Able (in the Investigators opinion) to comply with all study requirements * Can speak and read English Group 3- VT Group attending epilepsy monitoirng unit * Inpatient receiving video-telemetry epilepsy monitoring unit * Age birth to \<16 years * Parents willing and able to give informed consent * Able (in the Investigators opinion) and willing to comply with all study requirements * Can speak and read English Exclusion Criteria: Group 1 - CR-poly group * Unable to provide consent and no next of kin to provide consent on participants behalf * Treating clinician deems patient inappropriate to be included in study Group 2 - Apnoea group * No next of kin to provide consent on participants behalf * Treating clinician deems patient inappropriate to be included in study Group 3- VT Group attending epilepsy monitoirng unit * Unable to provide consent and no next of kin to provide consent on participants behalf * Treating clinician deems patient inappropriate to be included in study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Apnea of prematurity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Apnea apnea of prematurity epilepsy sleep apnea syndrome Sudden Unexpected Death in Epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Apnea of prematurity Respiratory rate Sleep-disordered breathing Sudden unexpected death in epilepsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Royal Hospital for Children, Glasgow

    RECRUITING

    Glasgow, Glasgow City, G51 4TF, United Kingdom

  • Royal Hospital for Children, Glasgow

    ACTIVE_NOT_RECRUITING

    Glasgow, Glasgow, G51 4TF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.